Germany differentiates lifestyle applications from medical applications by calling them DiGA, which is an abbreviation of Digitale Gesundheitsanwendungen, which means Digital Medical Applications. Those have to be approved by The Federal Institute for Drugs and Medical Devices. The posed expectations for DiGA candidates are high. The applications must be based on the newest scientific findings and undergo clinical validation.
Currently, the Asklepios Tumborzentrum Hamburg, an Asklepios Kliniken division, is testing the Living Well app under the responsibility of the medical director Dr. Georgia Schilling. Asklepios Kliniken is one of the three biggest private hospital operators in Germany.
30 patients go through the 22-lesson plan contained in the Living Well app. Another 30 patients form the control group and will gain the access to the app after the end of the study. Dr. Georgia Schilling is convinced that the app works “It teaches women how to be more mindful with themselves, in a playful and informative way,” - says the engaged Oncologist “They can better their quality of life, and treatment odds. Mental health is an absolute must for overcoming the illness”.
Read more at: https://gesundleben.asklepios.com/gesund-werden/therapie-und-nachsorge/krebstherapie-app/
Germany differentiates lifestyle applications from medical applications by calling them DiGA, which is an abbreviation of Digitale Gesundheitsanwendungen,
Daiichi Sankyo Germany seeks to support cancer care in a collaboration with Prosoma
for New Therapeutic Supporting Mental Health and Behavioural Needs of Cancer Patients